The potential role of the microbiome-gut-brain axis in this interaction.
StromaForte by Swedish StromaBio for Cardiovascular Disease: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes